Vividion Therapeutics
Latest round
- Series C
Last raised
- Feb 2021
Total raised
- $271M
Investors
- 23
About Vividion Therapeutics
Based in California, US, and founded in 2013, Vividion Therapeutics, Inc. operates as a biotechnology company that develops small molecule medicines that help patients with cancer and immune disorders. The was founded by Benjamin Cravatt, Jin-Quan Yu, and Phil Baran and has 105 employees as of July 2021.5 billion. Vividion Therapeutics, Inc. develops novel drug discovery platforms that focus on identifying undruggable targets for cancer. The company's platform has 3 main components: a novel chemoproteomic screening technology, an integrated data portal and a proprietary chemistry library. The firm's platform develops a variety of small molecule therapies across indications, with an initial focus on targets relevant to oncology and immunology. The company also provides NRF2 Program, STAT3 Program, and Werner (WRN) Program for various inflammatory diseases such as irritable bowel disease and others. The company generates revenue from collaboration agreements and as of March 2021, Vividion Therapeutics, Inc. has generated USD 14,941 in the first quarter of 2021. Vividion Therapeutics, Inc. The company plans to submit its first Investigational New Drug (IND) in 2022.
Who invested in Vividion Therapeutics
23 investors across 5 rounds
See all investors in Vividion Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Vividion Therapeutics
Who invested in Vividion Therapeutics?
Vividion Therapeutics has 23 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Vividion Therapeutics raised?
Vividion Therapeutics has raised 5 venture rounds. Sign up free to see how much each round raised and the total.
When did Vividion Therapeutics last raise money?
Vividion Therapeutics's most recent round on record is a Series C, in Feb 2021.
What does Vividion Therapeutics do?
Based in California, US, and founded in 2013, Vividion Therapeutics, Inc.
Where is Vividion Therapeutics headquartered?
Vividion Therapeutics is headquartered in San Diego, US.
Which VCs invest in companies like Vividion Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Vividion Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Vividion Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.